A Pennsylvania woman is one of the six who developed a rare blood clot after receiving the Johnson & Johnson Covid-19 vaccine.
Pennsylvania's acting Health Secretary Alison Beam had said Tuesday that officials did not think any of the women were from Pennsylvania, but were awaiting confirmation.
Administration of the J&J vaccine was paused nationwide on Tuesday to allow officials to review the data and determine if new safety recommendations are warranted.
A Centers for Disease Control & Prevention panel met Wednesday but adjourned without making a decision, leaving the suspension of J&J vaccine shots in place. The panel plans to meet again in a week to 10 days.
The women developed the clots between six and 13 days after receiving the vaccine. Nearly 7 million J&J doses were administered in the U.S. before the pause was announced.